Electronegative LDL induction of apoptosis in macrophages: Involvement of Nrf2

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 4, 2010, Pages 430-437

  Pedrosa, A M C ^a   Faine, L A ^a,b   Grosso, D M ^a   de Las Heras, B ^b   Bosca L ^c   Abdalla, D S P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Apoptosis; Electronegative LDL; Fas ligand; Nrf2; RAW macrophages

Indexed keywords

CASPASE; CASPASE INHIBITOR; CD36 ANTIGEN; FAS ANTIGEN; FAS LIGAND; LOW DENSITY LIPOPROTEIN; REACTIVE SULFUR SPECIES; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRICITY; HYPERPOLARIZATION; INCUBATION TIME; MACROPHAGE; MITOCHONDRIAL MEMBRANE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD36; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; FAS LIGAND PROTEIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 76549120707     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.12.001     Document Type: Article

References (38)

1. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int. J. Oncol. 22 (2003) 15-20
2. Liu J., Thewke D.P., Su Y.R., Linton M.F., Fazio S., and Sinensky M.S. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 174-179
3. Wajant H. The fas signaling pathway: more than a paradigm. J. Lipid Res. 48 (2007) 177-184
4. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis. the importance of lesion stage and phagocytic efficiency. Science 296 (2002) 1635-1636
5. -) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clin. Biochem. 39 (2006) 28-38
6. Calvo D., Gómez-Coronado D., Suárez Y., Lasunción M.A., and Vega M.A. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 39 (1998) 777-788
7. Febbraio M., Hajjar D.P., and Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108 (2001) 785-791
8. Yang C.Y., Raya J.L., Chen H.H., Chen C.H., Abe Y., Pownall H.J., Taylor A.A., and Smith C.V. Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1083-1090
9. Lu J., Jiang W., Yang J., Chang P., Walterscheid J.P., Chen H., Marcelli M., Tang D., Lee Y., Liao W.S.L., Yang C., Chen C., and Electronegative L.D.L. impairs vascular endothelial cell integrity in diabetes by disrupting FGF2 autoregulation. Diabetes 57 (2007) 158-166
10. Chen H.H., Hosken B.D., Huang M., Gaubatz J.W., Myers C.L., Macfarlane R.D., Pownall H.J., and Yang C.Y. Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic. J. Lipid Res. 48 (2007) 177-184
11. Sanchez-Quesada J.L., Benitez S., and Ordonez-Llanos J. Electronegative low-density lipoprotein. Curr. Opin. Lipidol. 15 (2004) 329-335
12. Demuth I K., Myara B., Chappey B., Vedie M.A., Pech-Amsellem M.E., and Haberland N. Moatti. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2255-2260
13. Havel R., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoprotein in human serum. J. Clin. Invest. 34 (1955) 1345-1353
14. Cazzolato G., Avogaro P., and Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Rad. Biol. Med. 11 (1991) 247-253
15. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., and Riccardi C.A. Rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139 (1991) 271-279
16. Floryk D., and Houtk J. Tetramethyl rhodamine methyl ester (TMRM) is suitable for cytofluorometric measurements of mitochondrial membrane potential in cells treated with digitonin. Biosc. Reports 19 (1999) 27-34
17. Carter W.O., Narayanan P.K., and Robinson J.P. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 55 (1994) 253-258
18. Peter M.E., Budd R.C., Desbarats J., Hedrick S.M., Hueber A.O., Newell K.M., Owen L.B., Pope R.M., Tschopp T., Wajant J.H., Wallach D., Wiltrout R.H., Zörnig M., and Lynch D.H. The CD95 receptor: apoptosis revisited. Cell 129 (2007) 447-450
19. Ishii T., Ken I., Emilio R., Leake D.S., Hiroyuki U., Yamamoto M., and Mann G.E. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages. Activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94 (2004) 609-616
20. Salvesen G.S., and Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell 91 (1997) 443-446
21. Lu J., Yang J.H., Burns A.R., Chen H.H., Tang D., Walterscheid J.P., Suzuki S., Yang C.Y., Sawamura T., and Chen C.H. Mediation of electronegative low-density lipoprotein signaling by LOX-1. A possible mechanism of endothelial apoptosis. Circ. Res. 104 (2009) 604-619
22. Richardson B.C., Lalwani N.D., Johnson K.J., and Marks R.M. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol. 24 (1994) 2640-2645
23. m) in apoptosis; an update. Apoptosis 8 (2003) 115-128
24. Boscá L., Zeini M., Través P.G., and Hortelano S. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Nitric Oxide, Cell Signalling Death Toxicol. 208 (2005) 249-258
25. Banki K., Hutter E., Gonchoroff N.J., and Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol. 162 (1999) 1466-1479
26. Gergely Jr. P., Niland B., Gonchoroff N., Pullmann Jr. R., Phillips P.E., and Perl A. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J. Immunol. 169 (2002) 1092-1101
27. Perl A., Gergely P., Nagy G., Koncz A., and Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 25 (2004) 360-367
28. Susin S.A., Zamzami N., Castedo M., Daugas E., Wang H., Geley S., Fassy F., Reed J.C., and Kroemer G. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186 (1997) 25-37
29. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., and Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275 (2000) 16023-16029
30. Chen X.L., Dodd G., Thomas S., Zhang X., Wasserman M.A., Rovin B.H., and Kunsch C. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1862-H1870
31. Liu X.M., Peyton K.J., Ensenat D., Wang H., Hannink M., Alam J., and Durante W. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc. Res. 75 (2007) 381-389
32. Kobayashi M., Li L., Iwamoto N., Nakajima-Takagi Y., Kaneko H., Nakayama Y., Eguchi M., Wada Y., Kumagai Y., and Yamamoto M. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol. 29 (2009) 493-502
33. Benítez S., Bancells C., Ordóñez-Llano J., and Sánchez-Quesada J.L. Pro-inflammatory action of LDL(-) on mononuclear cells is counteracted by increased IL10 production. Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids 1771 (2007) 613-622
34. Maruyama A., Tsukamoto S., Nishikawa K., Yoshida A., Harada N., Motojima K., Ishii T., Nakane A., Yamamoto M., and Itoh K. Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. Arch. Biochem. Biophys. 477 (2008) 139-145
35. Liang C.P., Han S., Okamoto H., Carnemolla R., Tabas I., Accili D., and Tall A.R. Increased CD36 protein as a response to defective insulin signaling in macrophages. J. Clin. Invest. 113 (2004) 764-773
36. Sussan T.E., Jun J., Thimmulappa R., Bedja D., Antero M., Gabrielson K.L., Polotsky V.Y., and Biswal S. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS ONE 3 (2008) 3791-3798
37. Ricote M., Li A., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
38. Fuhrman B., Volkova N., and Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclerosis 161 (2002) 307-316